Nycomed Looks To Sell Cancer Asset

Nycomed AS, a Danish drug company, is seeking a buyer for its cancer research operations, according to Financial Times Deutschland. No word yet on desired pricing. Nycomed acquired the assets as part of its 2006 purchase of Altana AG's pharmaceuticals division.


Nordic Capital holds a 51% stake in Nycomed, with other shareholders including DLJ Merchant Banking Partners, Blackstone Group and AlpInvest.